Lesson 11 of 20

It is weak — ten thousand times weaker than an antibody

TCR-pMHC KD of 1-100 µM · and the fact that this was the design

It is weak — ten thousand times weaker than an antibody
The most consequential binding event in immunology is one of the weakest.

The first people to measure TCR-pMHC binding strength did not believe the result.

KD = 1 to 100 micromolar

Antibody-antigen binding on the same scale is nanomolar, and the good ones are picomolar. Smaller means tighter. A TCR binds a thousand to a million times more weakly than an antibody.

The receptor that makes the body's most precise judgement binds the most loosely. That is not a failure. It is the design.

Coreceptors are weaker still than the TCR — CD4 is nearly millimolar.
Python Runs in your browser
And yet a T cell without CD4 does not respond. Something is missing from this picture.
Python Runs in your browser
Change the binding strength and the ligand concentration. Antibodies and TCRs live in different worlds.
Loading…

Why weak is an advantage — two reasons

🔁
One fragment wakes many
An infected cell may carry only a handful of copies of the fragment. If a TCR clamps down and never lets go, that fragment triggers exactly one TCR. Letting go quickly moves it to the next one. This is called serial triggering.
⚖️
It separates self from other
A receptor that binds hard also binds things that merely resemble its target — and self peptides mostly resemble pathogen peptides. Binding weakly is what lets you measure the difference in time — lesson 12.

A cytotoxic T cell is thought to be able to kill a target carrying only a countable handful of copies of a fragment. Weak binding is what makes that possible.

🤔 Check yourself
What does TCR-pMHC binding being far weaker than antibody-antigen most accurately mean?
🤔 Check yourself
The solution calculation says CD4 barely binds. Why is it needed anyway?
🤔 Check yourself
What does 'serial triggering' mean?